PDS Biotechnology
PDSB
PDSB
17 hedge funds and large institutions have $2.12M invested in PDS Biotechnology in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
82% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 17
Holders
17
Holding in Top 10
–
Calls
$102K
Puts
–
Top Buyers
| 1 | +$89.7K | |
| 2 | +$12.9K | |
| 3 | +$12.8K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3K |
| 5 |
FIA
FNY Investment Advisers
New York
|
+$1K |
Top Sellers
| 1 | -$753K | |
| 2 | -$78K | |
| 3 | -$76K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$51K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31K |